mesenquimatosoCélulas madre for Progressive Multiple Sclerosis_Sweden

To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSC) in Multiple Sclerosis (EM) with progressive disease status.


NB Ciencia

organización de contratos de investigación

terapia con células madre